Regeneron Pharmaceuticals, Inc. (0R2M.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:30PM BST
| Previous close | 1,033.14 |
| Open | 1,035.89 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 1,025.00 - 1,040.52 |
| 52-week range | 689.00 - 1,040.52 |
| Volume | |
| Avg. volume | 1,962 |
| Market cap | 115.159B |
| Beta (5Y monthly) | 0.13 |
| PE ratio (TTM) | 0.15 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Investor's Business Daily
Swing Trading Regeneron Stock Shows How To Bob And Weave
What do boxers and swing traders have in common? Avoiding big hits and striking at opportunities when they come. Here's how.
- Zacks
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Regeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic obstructive pulmonary disease indication in the EU.
- GuruFocus.com
Insider Sale: Director Arthur Ryan Sells Shares of Regeneron Pharmaceuticals Inc (REGN)
The transaction was documented in an SEC Filing. Following this transaction, the insider now owns 17,882 shares of Regeneron Pharmaceuticals Inc. Regeneron Pharmaceuticals Inc is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
© 2024 Yahoo. All rights reserved.